Tag: Sleep Apnea
In brief: Protect indie pharmacies, comment on NIV decision, fill sleep education gaps
March 14, 2025HME News Staff
WASHINGTON – A group of senators has introduced legislation to limit what they say are abusive pricing practices by pharmacy benefit managers.
The “Protecting Pharmacies in Medicaid Act,” introduced by Sens. Peter Welch, D-Vt., Roger Marshal, R-Kan., Mark Warner, D-Va., and Bill Cassidy, R-La., cracks down on what they call “spread pricing” - charging Medicaid more than PBMs charge pharmacies for a drug, driving up costs for Medicaid and short-changing pharmacies....
NSF wants to address ‘gaps’ in understanding of sleep apnea
March 12, 2025HME News Staff
WASHINGTON – Nearly one-third of adults diagnosed with sleep apnea are not currently receiving treatment, according to a new study from the National Sleep Foundation.
“Understanding Sleep Apnea Survey,” an independent research and report supported by Inspire Medical Systems, surveyed more than 1,000 U.S. adults to identify the public's current understanding of and attitudes about sleep apnea symptoms, treatment options and preferences, and consequences of untreated...
Dreem, Sunrise launch women’s health program
March 10, 2025HME News Staff
NEW YORK – Dreem Health, a digital sleep clinic managed by the Sunrise Group, has launched a women’s health program for women experiencing sleep issues due to pregnancy, PCOS, perimenopause, menopause and PMS. As part of the program, Dreem Health’s licensed providers will now evaluate their symptoms, diagnose their conditions using the Sunrise at-home sleep test device, and create a personalized treatment plan or refer them to a partner for further care. “As a company that...
Signifier meets CMS requirements for reimbursement
March 10, 2025HME News Staff
LONDON – Signifier Medical Technologies Limited has introduced its newest SKU, 18010, which features a hardware remote control specifically designed to meet CMS requirements for reimbursement. The company says the development ensures that its eXciteOSA therapy can be more readily accessible for Medicare and Medicaid beneficiaries. “eXciteOSA is a life-changing device helping patients address a root cause of sleep apnea and other sleep disorders,” said Mujtaba Chohan, head of finance...
Study: Sleep apnea linked to increased risk of Parkinson’s, but CPAP may reduce risk
March 4, 2025HME News Staff
MINNEAPOLIS – People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, CPAP therapy may reduce that risk, according to a preliminary study released March 2, 2025, that will be presented at the American Academy of Neurology's 77th Annual Meeting taking place April 5–9, 2025, in San Diego and online.
The study found using CPAP within two years of a sleep apnea diagnosis reduced the risk of Parkinson's.
"Obstructive...
Amino Health, GEM SLEEP connect patients
February 26, 2025HME News Staff
LOS ANGELES – A new partnership will enable members of Amino Health, a digital health care navigator, to seamlessly connect with GEM SLEEP, a virtual sleep apnea care provider, expanding access to in-network, proven sleep apnea treatment. "Sleep apnea is a serious but often overlooked health condition that impacts 30-plus million people, and of those, less than 20% have been diagnosed” said Brian Sauer, CEO of GEM SLEEP. "By integrating with Amino Health’s platform, we...
VGM ‘optimizes’ sleep journey with SleepGlad
February 14, 2025Liz Beaulieu, Editor
WATERLOO, Iowa – VGM Group’s acquisition of mask-fitting platform SleepGlad rounds out the company’s respiratory offering and better aligns it with a “massive shift” in patient care, as well as addresses a major pain point for providers, says Boone Lockard.
VGM already offers fulfillment and logistics services for CPAP machines and supplies through VGM Fulfillment, as well as virtual onboarding, patient setup, compliance and post-compliance monitoring...
Huxley Medical HST approved for cellular data capabilities
February 7, 2025HME News Staff
ATLANTA – Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, has received clearance from the U.S. Food and Drug Administration for its SANSA home sleep apnea test to begin using cellular data upload capabilities. The company says this breakthrough eliminates the need for Bluetooth pairing or smartphone apps commonly required to transmit test data to physicians, addressing a common source of failed home testing, while simplifying...
ResMed moves to address ‘educational gap’ on PAP devices, GLP-1s
January 31, 2025Liz Beaulieu, Editor
SAN DIEGO – In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep apnea, ResMed is ramping up its education to high-volume prescribers of GLP-1 drugs to reiterate that PAP therapy remains the gold standard.
The FDA announced in late December that it had approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe OSA in adults with obesity. It’s approved for use in combination...
In brief: Quipt ‘evaluates’ opposition, Henry Schein gets funding, Estrella steps up
January 31, 2025HME News Staff
CINCINNATI — Quipt Home Medical has acknowledged receiving notice from Philotimo Fund, an entity affiliated with Kanen Wealth Management and David L. Kanen, of its intent to solicit proxies in support of four director candidates in opposition to the company’s candidates.
The company says its board and the Nominating and Corporate Governance Committee of the board will thoroughly review and evaluate KWM’s notice and any additional requests for compliance with its established...